NSE BSE
zenith drugs limited stock

ZENITH DRUGS LIMITED Share Price

- - (%)
- NSE: ZENITHDRUG

ZENITH DRUGS LIMITED Share Price Update

As of the latest trading session, ZENITH DRUGS LIMITED share price is currently at 78, which is down by -3.09 from its previous closing. Today, the stock has fluctuated between 75.20 and 81.00. Over the past year, ZENITH DRUGS LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been 30.04 %. Read More...

ZENITH DRUGS LIMITED Performance

Day Range

Low75.20 High81.00
81.10

52 Week Range

Low 52.80 High 114.50
81.10

ZENITH DRUGS LIMITED Share Price

22803

ZENITHDRUG

img img img img
No Data Available

Open Price

79.05

Prev. Close

81.10

Volume (Shares)

230400.00

Total traded value

186.85

Upper Circuit

97.30

Lower Circuit

64.90

Note: The current prices & values are delayed, Login to your account for live updates.

ZENITH DRUGS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 3.12
PE Ratio (TTM) 14.83
Book Value / Share 36.28
Beta 0.96
ROE 28.55%
EPS (TTM) 6.41
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

ZENITH DRUGS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 131.62
Operating Expense 119.00
Net Profit 9.54
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 5.56
EBITDA 19.04
Effective Tax Rate (%) 25.50
Particulars MAR 2023 (Values in Cr)
Revenue 114.52
Operating Expense 109.10
Net Profit 4.88
Net Profit Margin (%) 4.26
Earnings Per Share (EPS) 122.03
EBITDA 10.29
Effective Tax Rate (%) 26.72
Particulars MAR 2022 (Values in Cr)
Revenue 91.66
Operating Expense 88.21
Net Profit 3.21
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 80.32
EBITDA 7.88
Effective Tax Rate (%) 27.04
Particulars MAR 2021 (Values in Cr)
Revenue 73.40
Operating Expense 68.91
Net Profit 3.07
Net Profit Margin (%) 4.18
Earnings Per Share (EPS) 76.66
EBITDA 7.31
Effective Tax Rate (%) 33.26
Particulars MAR 2020 (Values in Cr)
Revenue 77.52
Operating Expense 73.46
Net Profit 3.40
Net Profit Margin (%) 4.38
Earnings Per Share (EPS) 85.00
EBITDA 7.10
Effective Tax Rate (%) 30.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 431.11
ROE % 35.12
ROCE % 26.52
Total Debt to Total Equity 1.53
EBITDA Margin 9.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 302.27
ROE % 25.89
ROCE % 21.47
Total Debt to Total Equity 1.56
EBITDA Margin 8.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 321.27
ROE % 28.55
ROCE % 23.89
Total Debt to Total Equity 1.43
EBITDA Margin 7.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 240.95
ROE % 37.88
ROCE % 27.83
Total Debt to Total Equity 1.70
EBITDA Margin 9.01
Particulars MAR 2020 (Values in Cr)
Book Value / Share 164.29
ROE % 51.75
ROCE % 33.21
Total Debt to Total Equity 1.84
EBITDA Margin 8.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 97.93
Total Liabilities 97.93
Total Equity 17.25
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 5.26
Return on Capital (%) 11.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.00
Total Assets 68.58
Total Liabilities 68.58
Total Equity 12.10
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 4.57
Return on Capital (%) 10.15
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.88
Total Assets 66.18
Total Liabilities 66.18
Total Equity 12.85
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 4.85
Return on Capital (%) 10.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.84
Total Assets 46.54
Total Liabilities 46.54
Total Equity 9.63
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 6.58
Return on Capital (%) 12.21
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 43.72
Total Liabilities 43.72
Total Equity 6.57
Share Outstanding 400000
Price to Book Ratio 0.00
Return on Assets (%) 7.77
Return on Capital (%) 22.9
Particulars MAR 2023 (Values in Cr)
Net Income 7.21
Cash from Operations -2.50
Cash from Investing 0.10
Cash from Financing 4.90
Net change in Cash 0.60
Free Cash Flow 0.40
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.47
Cash from Investing -5.24
Cash from Financing 1.24
Net change in Cash 1.15
Free Cash Flow 9.05
Particulars MAR 2022 (Values in Cr)
Net Income 4.40
Cash from Operations 6.15
Cash from Investing 2.60
Cash from Financing -0.83
Net change in Cash 6.68
Free Cash Flow 6.15
Particulars MAR 2021 (Values in Cr)
Net Income 4.60
Cash from Operations 0.47
Cash from Investing -1.42
Cash from Financing 2.88
Net change in Cash 0.56
Free Cash Flow 1.90
Particulars MAR 2020 (Values in Cr)
Net Income 4.87
Cash from Operations 4.99
Cash from Investing -4.93
Cash from Financing 1.35
Net change in Cash -0.09
Free Cash Flow 9.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
ZENITH DRUGS LIMITED 82.45 12.98 2.27 141.39 52.80 / 114.50
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ZENITH DRUGS LIMITED 82.45 12.86 2.27 141.39 52.80 / 114.50
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 72.40
  • 26 Days 65.90
  • 10 Days 68.60
  • 50 Days 65.20
  • 12 Days 67.90
  • 100 Days 72.20
  • 20 Days 66.20
  • 200 Days 101.80
83.05
PIVOT
First Resistance 88.20
Second Resistance 93.95
Third Resistance 99.10
First Support 77.30
Second Support 72.15
Third Support 66.40
RSI 89.23
MACD 1.97
Commodity Channel Index (CCI) 472.42
ADX 26.90
Williams % R -23.69

Over 1 Month

down

30.04

Over 3 Months

down

29.53

Over 6 Months

down

-21.58

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

ZENITH DRUGS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ZENITH DRUGS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
24.21
Promoter Holdings
69.97
FII
5.81
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ajay Singh Dassundi Shareholding of Promoter and Promoter Group 3861990.0 22.52
Sandeep Bhardwaj Shareholding of Promoter and Promoter Group 3666990.0 21.38
Bhupesh Soni Shareholding of Promoter and Promoter Group 3460980.0 20.18
Gretex Share Broking Limited Public Shareholding 595200.0 3.47
Jaywanti Soni Shareholding of Promoter and Promoter Group 504000.0 2.94
Meru Investment Fund Pcc-cell 1 Public Shareholding 377600.0 2.2
Priyanka Bharadwaj Shareholding of Promoter and Promoter Group 333000.0 1.94
Aries Opportunities Fund Limited Public Shareholding 252800.0 1.47
Vikasa India Eif I Fund - Zodiac Global Opportunity Fund Public Shareholding 211200.0 1.23
Yuga Stocks And Commodities Private Limited Public Shareholding 200000.0 1.17
Praveen Mudunuri Public Shareholding 190400.0 1.11
Neomile Growth Fund - Series I Public Shareholding 190400.0 1.11
Anjali Dassundi Shareholding of Promoter and Promoter Group 138000.0 0.8
Saroj Soni Shareholding of Promoter and Promoter Group 35040.0 0.2

ZENITH DRUGS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ZENITH DRUGS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ZENITH DRUGS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Zenith Drugs Ltd?

Answer Field

The share price of Zenith Drugs Ltd for NSE is ₹ 78 and for BSE is ₹ 0.00.

What is the Market Cap of Zenith Drugs Ltd?

Answer Field

The market cap of Zenith Drugs Ltd for NSE is ₹ 3.12 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Zenith Drugs Ltd?

Answer Field

The 52 Week High and Low of Zenith Drugs Ltd for NSE is ₹ 114.50 and ₹ 52.80 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Zenith Drugs Ltd share?

Answer Field

You can trade in Zenith Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Zenith Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader